Empty Capsules Market Size, Share and Growth Outlook, 2026

Empty Capsules Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Empty Capsules Market size is forecast to increase from $4.15 Billion in 2026 to $6.92 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034.

The Empty Capsules market report provides detailed analysis and outlook of Empty Capsules segments including By Product Type (Gelatin Capsules, Non-Gelatin Capsules ), By Raw Material Source (Animal-based, Plant-based ), By Functionality (Immediate-Release Capsules, Sustained, Delayed), By Therapeutic Application (Antibiotic & Antibacterial, Vitamins & Dietary Supplements, Cardiovascular Therapy, Pain Management & CNS, Antacid & Antiflatulent), By End-User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetic & Personal Care Industry, Contract Development & Manufacturing Organizations) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Empty Capsules Industry Overview

Strategic Industry Transformation and Manufacturing Ownership Changes

The empty capsules industry is undergoing significant structural transformation as manufacturers realign their business portfolios and production strategies. A major industry development is the divestiture of Lonza Group AG’s Capsules & Health Ingredients (CHI) business, originally established through the Capsugel brand, to Lone Star Funds in a transaction valued at approximately CHF 2.3 billion. This strategic transaction enables Lonza to focus exclusively on biologics and small molecule Contract Development and Manufacturing Organization (CDMO) services while transferring ownership of its extensive global hard empty capsule manufacturing network to Lone Star Funds. The transaction highlights the growing importance of specialized capsule production assets within the pharmaceutical and nutraceutical supply chain.

Growing Demand for Plant-Based and Organic Empty Capsules

The market is experiencing increasing demand for plant-based, vegan, and organic capsule solutions as pharmaceutical and nutraceutical manufacturers respond to evolving consumer preferences and regulatory requirements. Prior to the completion of its divestiture, Lonza’s CHI division introduced Organicaps™, a plant-based immediate-release empty capsule platform. The product represents the industry's first USDA organic-certified capsule line manufactured within North American facilities. The innovation enables pharmaceutical and dietary supplement companies to simplify sourcing requirements for organic and vegan solid-dose formulations while strengthening regional supply chain resilience. The emergence of certified organic empty capsules reflects the industry's broader shift toward clean-label and sustainable healthcare products.

Sustainability Initiatives Reshaping Capsule Manufacturing

Sustainability has become a critical focus area across the empty capsules industry. Lonza Capsugel implemented a significant infrastructure modernization project at its Bornem, Belgium manufacturing facility through a long-term power purchase agreement that integrates locally generated wind energy into hard capsule production operations. The initiative supports corporate decarbonization objectives while reducing the environmental footprint of high-volume capsule extrusion processes. As environmental regulations and sustainability expectations continue to increase, capsule manufacturers are investing in renewable energy integration and energy-efficient production systems.

Advanced Manufacturing Supporting Pharmaceutical Applications

The empty capsules market continues to benefit from investments in advanced manufacturing technologies, quality assurance systems, and specialized formulation compatibility. Hard empty capsules remain essential delivery systems for prescription pharmaceuticals, nutraceuticals, dietary supplements, and botanical products. Growing demand for vegetarian capsules, organic-certified formats, and sustainable manufacturing practices is driving innovation across capsule materials, production methods, and supply chain infrastructure. These developments are strengthening the role of empty capsules as a critical component of modern oral solid dosage manufacturing.

Empty Capsules Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Empty Capsules market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Lonza Group AG (Capsugel), ACG Worldwide, Qualicaps Co., Ltd. (Mitsubishi Chemical Group), Suheung Co., Ltd., CapsCanada Corporation (Lyfe Group), Sunil Healthcare Limited, Lefancaps Ltd., Roxlor LLC, Healthcaps India Ltd., Natural Capsules Limited. The Empty Capsules market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Empty Capsules industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Empty Capsules Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Empty Capsules companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Empty Capsules markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Empty Capsules Market Competitive Benchmarking and Company Analysis

Leading companies in Empty Capsules industry include- Lonza Group AG (Capsugel), ACG Worldwide, Qualicaps Co., Ltd. (Mitsubishi Chemical Group), Suheung Co., Ltd., CapsCanada Corporation (Lyfe Group), Sunil Healthcare Limited, Lefancaps Ltd., Roxlor LLC, Healthcaps India Ltd., Natural Capsules Limited. The Empty Capsules market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Empty Capsules Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Empty Capsules market remains one of the strongest-performing segments in the country.
The US Empty Capsules Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Empty Capsules market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Empty Capsules industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Empty Capsules markets

Canada's strong Empty Capsules sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Empty Capsules market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Empty Capsules Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Empty Capsules market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Empty Capsules population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Empty Capsules industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Empty Capsules market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Empty Capsules sales through 2034

France Empty Capsules companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Empty Capsules Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Empty Capsules distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Empty Capsules Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Empty Capsules market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Empty Capsules industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Empty Capsules industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Empty Capsules Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Empty Capsules market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Empty Capsules market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Empty Capsules Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Empty Capsules Market Segmentation

By Product Type
Gelatin Capsules
Non-Gelatin Capsules
By Raw Material Source
Animal-based
Plant-based
By Functionality
Immediate-Release Capsules
Sustained
Delayed
By Therapeutic Application
Antibiotic & Antibacterial
Vitamins & Dietary Supplements
Cardiovascular Therapy
Pain Management & CNS
Antacid & Antiflatulent
By End-User
Pharmaceutical Industry
Nutraceutical Industry
Cosmetic & Personal Care Industry
Contract Development & Manufacturing Organizations

Top Companies in Empty Capsules Industry

Lonza Group AG (Capsugel)
ACG Worldwide
Qualicaps Co., Ltd. (Mitsubishi Chemical Group)
Suheung Co., Ltd.
CapsCanada Corporation (Lyfe Group)
Sunil Healthcare Limited
Lefancaps Ltd.
Roxlor LLC
Healthcaps India Ltd.
Natural Capsules Limited

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025